These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32114514)

  • 41. Gynecological carcinosarcomas: Overview and future perspectives.
    Collet L; González López AM; Romeo C; Méeus P; Chopin N; Rossi L; Rowinski E; Serre AA; Rannou C; Buisson A; Treilleux I; Ray-Coquard I
    Bull Cancer; 2023 Nov; 110(11):1215-1226. PubMed ID: 37679206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.
    Watanabe M; Shimizu K; Kato H; Imai H; Nakano H; Sugawa M; Shiraishi T
    Gynecol Oncol; 2001 Sep; 82(3):563-7. PubMed ID: 11520156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two Components of Variant Profiles in Primary Vaginal Carcinosarcoma via Next-Generation Sequencing and a Literature Review.
    Kotoku R; Yanazume S; Kuroda T; Kobayashi Y; Kitazono I; Akahane T; Tanimoto A; Kobayashi H
    Int J Surg Pathol; 2022 May; 30(3):288-294. PubMed ID: 34463147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microsatellite instability in uterine sarcomas.
    Amant F; Dorfling CM; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
    Int J Gynecol Cancer; 2001; 11(3):218-23. PubMed ID: 11437928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogene alterations in endometrial carcinosarcomas.
    Biscuola M; Van de Vijver K; Castilla MÁ; Romero-Pérez L; López-García MÁ; Díaz-Martín J; Matias-Guiu X; Oliva E; Palacios Calvo J
    Hum Pathol; 2013 May; 44(5):852-9. PubMed ID: 23199529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma.
    Fantappiè G; Malentacchi F; Turrini I; Sorbi F; Castiglione F; Vergoni F; Ammatuna C; Antonuzzo L; Fambrini M; Noci I; Pillozzi S
    Anticancer Drugs; 2020 Sep; 31(8):880-883. PubMed ID: 32796408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
    Mi S; Lin M; Brouwer-Visser J; Heim J; Smotkin D; Hebert T; Gunter MJ; Goldberg GL; Zheng D; Huang GS
    Clin Cancer Res; 2016 Sep; 22(18):4676-86. PubMed ID: 27121792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma.
    Gotoh O; Sugiyama Y; Takazawa Y; Kato K; Tanaka N; Omatsu K; Takeshima N; Nomura H; Hasegawa K; Fujiwara K; Taki M; Matsumura N; Noda T; Mori S
    Nat Commun; 2019 Oct; 10(1):4965. PubMed ID: 31672974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas.
    Hoang LN; Ali RH; Lau S; Gilks CB; Lee CH
    Int J Gynecol Pathol; 2014 Sep; 33(5):483-91. PubMed ID: 25083964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
    Zhao S; Choi M; Overton JD; Bellone S; Roque DM; Cocco E; Guzzo F; English DP; Varughese J; Gasparrini S; Bortolomai I; Buza N; Hui P; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Carrara L; Pecorelli S; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Stiegler AL; Mane S; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2916-21. PubMed ID: 23359684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.
    Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S
    Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of alternative lengthening of telomeres-associated biomarkers in uterine sarcoma and uterine carcinosarcoma.
    Lee YK; Park NH; Lee H
    Int J Gynecol Cancer; 2012 Mar; 22(3):434-41. PubMed ID: 22266933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
    Pinto A; Mackrides N; Nadji M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.
    Cuppens T; Depreeuw J; Annibali D; Thomas D; Hermans E; Gommé E; Trinh XB; Debruyne D; Moerman P; Lambrechts D; Amant F
    Gynecol Oncol; 2017 Sep; 146(3):538-545. PubMed ID: 28625393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
    Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcriptional regulation of the alpha-1 type II collagen gene by nuclear factor B/p65 and Sox9 in the chondrocytic phenotype of uterine carcinosarcomas.
    Yoshida T; Hashimura M; Kuwata T; Matsumoto T; Suzuki E; Tazo Y; Nakajima H; Inukai M; Saegusa M
    Hum Pathol; 2013 Sep; 44(9):1780-8. PubMed ID: 23618358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
    da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
    Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
    Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
    Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.
    Laforest A; Aparicio T; Zaanan A; Silva FP; Didelot A; Desbeaux A; Le Corre D; Benhaim L; Pallier K; Aust D; Pistorius S; Blons H; Svrcek M; Laurent-Puig P
    Eur J Cancer; 2014 Jul; 50(10):1740-1746. PubMed ID: 24797764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.